High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation

Anticancer Research

Volumn 25, Issue 3 C, 2005, Pages 2471-2475

  Harada, Koji ^a   Supriatno, ^a   Kawaguchi, Shin Ichi ^a   Kawashima, Yuichiro ^a   Itashiki, Yasutaka ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Immunohistochemistry; Prognosis; Radiation; Skp2; UFT

Indexed keywords

S PHASE KINASE ASSOCIATED PROTEIN 2; UFT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 22944478030     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kip1 protein: prognostic implications in primary breast cancer. Nature Med 3: 227-230, 1997.
2. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG et al: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997.
3. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K et al: p27 expression and gastric carcinoma. Nature Med 3: 593, 1997.
4. Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma. Anticancer Res 22: 2985-2989, 2002.
5. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154: 313-323, 1999.
6. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T et al: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/ in human malignancies. Cancer Res 55: 2266-2269, 1995.
7. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995.
8. Zhang H, Kobayashi R, Galaktionov K and Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82: 915-925, 1995.
9. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G and Pagano M: Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci USA 98: 2515-2520, 2001.
10. Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 91: 1745-1751, 2001.
11. Chiarle R, Fan Y, Piva R, Boggino H, Skolnik J, Novero D, Palestro G, De Wolf-Peeters C, Chilosi M, Pagano M and Inghirami G: S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 160: 1457-1466, 2002.
12. Gstaigert M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 98: 5043-5048, 2001.
13. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I and Takata T: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 61: 7044-7047, 2001.
14. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K, Nakayama K and Mori M: Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62: 3819-3825, 2002.
15. Johnson NW: Epidemiology of oral cancer in risk markers of oral disease. In: Johnson NW, ed. Oral Cancer, vol. 2. Cambridge, UK: Cambridge University Press, pp. 3-26, 1991.
16. Thomas GJ, Jones J and Speight PM: Integrins and oral cancer. Oral Oncol 33: 381-388, 1997.
17. Ramos DM, Chen BL, Boylen K, Stern M, Kvamer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L and Pytela R: Stromal fibroblast influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int J Cancer 72: 369-372, 1997.
18. Silverman S Jr: Oral Cancer, 4th. ed, BC Becker, Ontario, 1998.
19. Sobin LH and Wittekind Ch: TNM Classification of Malignant Tumours. International Union Against Cancer (UICC), Ed. 5. New York: Wiley-Liss, pp. 20-37, 1997.
20. Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154: 313-323, 1999.
21. Carrano AC, Eytan E, Hershko A and Pagano M: Skp2 is required for ubiquitin-mediated degradation of the Cdk inhibitor p27. Nat Cell Biol 1: 193-197, 1999.
22. Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1: 207-214, 1999.
23. KIP1 and poor prognosis in oral squamous cell carcinomas. Oncology 65: 355-362, 2003.